Viewing Study NCT01562405


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-01-11 @ 2:01 PM
Study NCT ID: NCT01562405
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-07
First Post: 2012-01-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Sponsor: Massachusetts General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed View
None Refractory View